{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:00:05Z","timestamp":1772672405596,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003509","name":"\u00d6rebro University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijcha.2025.101709","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T06:15:27Z","timestamp":1748672127000},"page":"101709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antiarrhythmic drug use in atrial fibrillation among different European countries \u2013 as determined by a physician survey"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-9427","authenticated-orcid":false,"given":"Espen","family":"Fengsrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Blomstr\u00f6m-Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"John Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Saksena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Reiffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101709_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcha.2025.101709_b0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Wang","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0015","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation \u2014 the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0020","article-title":"Tromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk","volume":"1","author":"Mobley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2022.100386","article-title":"Temporal trends and patterns in atrial fibrillation incidence: a population-based study of 3\u00b7 4 million individuals","volume":"17","author":"Wu","year":"2022","journal-title":"Lancet Regional Health\u2013Europe"},{"key":"10.1016\/j.ijcha.2025.101709_b0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ijcha.2025.101709_b0035","unstructured":"Infinium Global Research. Cardiac ablation market opportunities, size, share, emerging trends, technological innovation, forecasts & regional analysis (Latin America, North America, Asia Pacific, Europe, Middle East). SDKI. Published November 2020. Accessed June 2021. https:\/\/www.sdki.jp\/reports\/cardiac-ablation-market\/103783."},{"key":"10.1016\/j.ijcha.2025.101709_b0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023838","article-title":"AIM-AF: a physician survey in the United States and Europe","volume":"11","author":"Camm","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2025.101709_b0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2288-11-126","article-title":"A randomized trial and economic evaluation of the effect of response mode on response rate, response bias, and item non-response in a survey of doctors","volume":"11","author":"Scott","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ijcha.2025.101709_b0050","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.2196\/jmir.6318","article-title":"Incentive and reminder strategies to improve response rate for internet-based physician surveys: a randomized experiment","volume":"18","author":"Cook","year":"2016","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.ijcha.2025.101709_b0055","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00392-016-0999-4","article-title":"Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation.Insights from the REPOSI study","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin Res Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101709_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae012","article-title":"Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physiciansurvey-how are we dealing with controversial approaches?","volume":"26","author":"Guerra","year":"2024","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.ijcha.2025.101709_b0065","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","article-title":"The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Camm","year":"2022","journal-title":"J Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101709_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae122","article-title":"Antiarrhythmic drugs in the era of atrial fibrillation ablation","author":"Boriani","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.ijcha.2025.101709_b0075","doi-asserted-by":"crossref","unstructured":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: a comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. (2002) 347 1825\u20131833.","DOI":"10.1056\/NEJMoa021328"},{"key":"10.1016\/j.ijcha.2025.101709_b0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jjcc.2019.10.002","article-title":"Successful catheter ablation improves exercise tolerance in persistent atrial fibrillation patients, especially those with reduced ventricular contraction, preserved atrial function, or a high CHADS2 score","volume":"75","author":"Katayama","year":"2020","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101709_b0085","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/HCQ.0000000000000011","article-title":"Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control","volume":"7","author":"Ha","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.ijcha.2025.101709_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.10.005","article-title":"Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial","volume":"220","author":"Slee","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2025.101709_b0095","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005051","article-title":"Treatment of atrial fibrillation and concordance with the American heart association\/American college of cardiology\/heart rhythm society guidelines: findings from ORBIT-AF (Outcomes registry for better informed treatment of atrial fibrillation)","volume":"10","author":"Barnett","year":"2017","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcha.2025.101709_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2796.2011.02395.x","article-title":"The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events","volume":"270","author":"Almroth","year":"2011","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101709_b0115","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/europace\/eut204","article-title":"Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF","volume":"15","author":"Chiang","year":"2013","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101709_b0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101709_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.20452\/pamw.15146","article-title":"Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey","volume":"130","author":"Kozie\u0142","year":"2020","journal-title":"Polish Arch. Int. Med."},{"key":"10.1016\/j.ijcha.2025.101709_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2021.02.041","volume":"333","author":"Kozie\u0142","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101709_b0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008961","article-title":"Guideline-concordant antiarrhythmic drug use in the Get with the Guidelines Atrial Fibrillation Registry","volume":"14","author":"Field","year":"2021","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcha.2025.101709_b0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2018.06.018","article-title":"Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs","volume":"205","author":"Friberg","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2025.101709_b0145","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2014.02.601","article-title":"Safety of dronedarone in routine clinical care","volume":"63","author":"Friberg","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcha.2025.101709_b0150","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/euhj.2000.2546","article-title":"Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol","volume":"22","author":"Plewan","year":"2001","journal-title":"Eur Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101709_b0155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101709_b0160","unstructured":"Van Gelder, I.C., Rienstra, M., Bunting, K. V et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur. Heart J., ehae176."},{"key":"10.1016\/j.ijcha.2025.101709_b0165","article-title":"An international physician survey of current ablation practices in atrial fibrillation: an AIM-AF substudy","author":"Saksena","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijcha.2025.101709_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2024.11.020","article-title":"Arrhythmia recurrence and rhythm control strategies after catheter ablation of newly 4 diagnosed atrial fibrillation (ARRC-AF Study)","author":"Saksena","year":"2025","journal-title":"JACC Clin. Electrophysiol."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101709_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"EP Europace"},{"key":"10.1016\/j.ijcha.2025.101709_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf076","article-title":"Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European heart rhythm association of the ESC","author":"Merino","year":"2025","journal-title":"Europace"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:18:08Z","timestamp":1762622288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S2352906725001125"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101709","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiarrhythmic drug use in atrial fibrillation among different European countries \u2013 as determined by a physician survey","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101709"}}